Marshall Wace North America’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,213
| Closed | -$499K | – | 1742 |
|
|
2021
Q1 | $499K | Buy |
+33,213
| New | +$499K | ﹤0.01% | 1173 |
|
|
2020
Q3 | – | Sell |
-14,598
| Closed | -$168K | – | 1491 |
|
|
2020
Q2 | $168K | Sell |
14,598
-35,434
| -71% | -$408K | ﹤0.01% | 1082 |
|
|
2020
Q1 | $519K | Buy |
50,032
+3,564
| +8% | +$37K | ﹤0.01% | 748 |
|
|
2019
Q4 | $763K | Sell |
46,468
-33,000
| -42% | -$542K | ﹤0.01% | 755 |
|
|
2019
Q3 | $1.06M | Buy |
+79,468
| New | +$1.06M | 0.01% | 680 |
|
|
2013
Q4 | $224K | Buy |
+18,036
| New | +$224K | ﹤0.01% | 628 |
|
|
2013
Q3 | – | Sell |
-11,856
| Closed | -$96K | – | 718 |
|
|
2013
Q2 | $96K | Buy |
+11,856
| New | +$96K | 0.01% | 412 |
|